Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on CN119751313B. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN119751313B enables efficient synthesis. Reduces cost and lead time for high-purity pharmaceutical intermediates via novel SuFEx chemistry.